Establishment Labs Holdings Inc. (NASDAQ:ESTA) Short Interest Up 8.1% in March

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 4,930,000 shares, a growth of 8.1% from the March 15th total of 4,560,000 shares. Based on an average trading volume of 457,400 shares, the days-to-cover ratio is currently 10.8 days. Currently, 21.7% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Citigroup upped their price objective on Establishment Labs from $49.00 to $60.00 and gave the stock a "buy" rating in a research note on Wednesday, April 3rd. Stephens restated an "overweight" rating and set a $47.00 price objective on shares of Establishment Labs in a research note on Thursday, January 11th. JPMorgan Chase & Co. upped their price objective on Establishment Labs from $46.00 to $53.00 and gave the stock an "overweight" rating in a research note on Thursday, February 29th. Finally, Mizuho upped their price objective on Establishment Labs from $50.00 to $65.00 and gave the stock a "buy" rating in a research note on Monday, April 1st. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $63.33.

Institutional Trading of Establishment Labs

Several institutional investors have recently modified their holdings of ESTA. Brown Advisory Inc. lifted its holdings in shares of Establishment Labs by 63.9% in the fourth quarter. Brown Advisory Inc. now owns 2,428,792 shares of the company's stock valued at $62,881,000 after buying an additional 946,612 shares during the period. Findell Capital Management LLC acquired a new stake in shares of Establishment Labs in the fourth quarter valued at $14,680,000. Fourth Sail Capital LP acquired a new stake in shares of Establishment Labs in the fourth quarter valued at $14,473,000. Millennium Management LLC lifted its holdings in shares of Establishment Labs by 2,021.2% in the second quarter. Millennium Management LLC now owns 419,059 shares of the company's stock valued at $22,788,000 after buying an additional 399,303 shares during the period. Finally, Cowen AND Company LLC lifted its holdings in shares of Establishment Labs by 18.1% in the third quarter. Cowen AND Company LLC now owns 1,141,172 shares of the company's stock valued at $55,997,000 after buying an additional 175,000 shares during the period. Institutional investors and hedge funds own 72.91% of the company's stock.

Establishment Labs Stock Performance

Shares of NASDAQ:ESTA traded up $0.41 on Wednesday, hitting $52.15. The company's stock had a trading volume of 202,493 shares, compared to its average volume of 435,909. Establishment Labs has a 12 month low of $16.96 and a 12 month high of $77.55. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of -17.15 and a beta of 1.24. The stock's 50-day moving average is $46.65 and its two-hundred day moving average is $36.20. The company has a debt-to-equity ratio of 10.26, a quick ratio of 1.67 and a current ratio of 3.06.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.79) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.95) by $0.16. The company had revenue of $31.60 million during the quarter, compared to analysts' expectations of $31.44 million. Establishment Labs had a negative return on equity of 357.81% and a negative net margin of 47.53%. The company's revenue for the quarter was down 27.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.55) earnings per share. On average, equities research analysts forecast that Establishment Labs will post -1.58 EPS for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.